Weis Markets, Inc. (NYSE:WMK) reported its financial results for the 13-week third quarter and 39-week year-to-date period ended September 26, 2026, in a press release issued November 3, 2026.

Key Highlights

  • Total revenue up 3.0%: Third quarter total revenue reached $1.28 billion, compared to $1.24 billion for the same period in 2025.
  • Net income rose 31.4%: Third quarter net income was $22.21 million, up from $16.90 million in the prior-year quarter.
  • Earnings per share: Basic and diluted EPS for the quarter was $0.90, compared to $0.69 in Q3 2025.
  • Gross profit margin expanded: Third quarter gross profit margin increased to 25.5% from 24.8% in 2025, with gross profit rising 5.8% to $324.61 million.
  • Pharmacy pricing headwind: Inflation Reduction Act Medicare maximum fair price provisions reduced third quarter revenue by approximately $14.56 million, cutting total revenue growth by approximately 1.2 percentage points.
  • Quarterly dividend declared: The Board declared a quarterly cash dividend of $0.34 per share, payable November 23, 2026, to shareholders of record as of November 9, 2026.
  • Year-to-date net income: For the 39-week period, net income totaled $72.92 million, an 18.1% increase over $61.73 million in the prior-year period.

Weis Markets Third Quarter 2026 Financial Performance

According to the filing, third quarter total revenue of $1.28 billion was driven primarily by higher fuel sales and sales from new stores. These gains were partially offset by lower overall sales in pharmacy, dairy, and produce. Pharmacy sales faced headwinds from Inflation Reduction Act Medicare maximum fair price provisions effective January 1, 2026, while dairy sales reflected lower egg pricing and produce sales were affected by reduced customer demand during a Cyclospora outbreak. Comparable store sales increased 1.3%, while comparable store sales excluding fuel decreased 1.2%.

The company disclosed that third quarter gross profit increased 5.8% to $324.61 million, with gross profit margin rising to 25.5% from 24.8% in the prior year. According to Chairman, President and CEO Jonathan H. Weis, "Improved store inventory shrink performance and lower costs within our internal supply chain helped drive a higher gross profit margin." Income from operations increased 38.6% to $28.51 million. The company noted that the increase in operating income more than offset lower investment income and a higher effective income tax rate, resulting in net income of $22.21 million and EPS of $0.90.

For the 39-week year-to-date period, the company reported total revenue of $3.81 billion, a 4.1% increase from $3.66 billion in the prior-year period. Year-to-date gross profit increased 7.8% to $983.26 million, and gross profit margin rose to 25.9% from 25.0% in 2025. Income from operations increased 28.6% to $93.31 million, and year-to-date EPS totaled $2.95, compared to $2.38 for the same period in 2025. The Inflation Reduction Act pharmacy pricing changes reduced year-to-date revenue by approximately $32.75 million, the filing disclosed.

What Was Disclosed

Weis Markets disclosed its Q3 and year-to-date 2026 financial results, showing revenue growth of 3.0% and 4.1% respectively, net income gains driven by improved gross margins, and a quarterly cash dividend of $0.34 per share declared October 29, 2026.